Biotech Stock Roundup: Celgene, Biogen, ABBV Posted Q4 Results, Catabasis Falls On DMD Data
February 02, 2017 at 08:56 AM EST
Companies like Celgene, Biogen and AbbVie reported fourth quarter results last week. Catabasis suffered a major setback with its lead pipeline candidate edasalonexent failing to meet the primary endpoint.
